Redefining What’s Possible for Millions Struggling with Anxiety and Depression
Faster. Safer. Better. These outcomes are the clarion calls of millions of people in the U.S. and around the world seeking better treatments for anxiety and depression. At Vistagen, we know that patients are searching for bold changes to improve their lives. We are on a mission — a mission to radically change the trajectory of mental health care through our distinct therapeutic approaches – One Mind at a TimeTM.
Our executive team is made up of visionary thinkers and experts, dedicated to positioning Vistagen for long-term success.
Reid Adler, J.D.
Chief Corporate Development Officer and General Counsel
Ross A. Baker, Ph.D., MBA,
Vice President, Global Medical Affairs
Erik Berglund, M.D., Ph.D., R.A.C.
Vice President, Global Regulatory Affairs
Allen (Jo) Cato, III Ph.D.
Senior Vice President, Development Operations
Jerrold D. Dotson, CPA
Vice President, Chief Financial Officer and Secretary
Vice President, Human Resources
Vice President, Investor Relations
Mark J. Ginski, Ph.D.
Senior Vice President, Head of CMC
Rita E. Hanover, Ph.D., R.A.C.
Vice President, Biostatistics and Clinical Analytics
Jessica R. Haskell J.D.
Vice President, Associate General Counsel
Jaakko Lappalainen, M.D., Ph.D.
Senior Vice President, Medical Research & Pharmacovigilance
Mark A. McPartland
Vice President of Corporate Development
Louis Monti, M.D., Ph.D.
Vice President, Translational Medicine
Joshua Prince, MBA
Senior Vice President, Business Operations
Shawn K. Singh, J.D.
Chief Executive Officer and Director
Vice President, Quality Assurance